Recombinant human granulocyte colony-stimulating factor after kidney transplantation: A retrospective analysis to evaluate the benefit or risk of immunostimulation

Transplantation

Volumn 69, Issue 4, 2000, Pages 527-531

  Schmaldienst, Sabine ^a   Bekesi, Gabor ^a   Deicher, Robert ^a   Franz, Martina ^a   Hörl, Walter H ^a   Pohanka, Erich ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; PREDNISOLONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ARTICLE; BLOOD CELL COUNT; BLOOD TOXICITY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LEUKOPENIA; PRIORITY JOURNAL;

EID: 0034012136     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200002270-00011     Document Type: Article

References (40)

1. Crawford J, Ozer H, Stoller R, et al. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med 1991; 325: 164.
2. Trillet-Lenoir V, Green J, Manegold C, et al. Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy. Eur J Cancer 1993; 29A: 319.
3. Sheridan WP, Morstyn G, Wolf M, et al. Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation. Lancet 1989; 2: 891.
4. Hollingshead LM, Goa KL. Recombinant granulocyte colony-stimulating factor: a review of its pharmacological properties and prospective role in neutropenic conditions. Drugs 1991; 42: 300.
5. Hammond WP, Price TH, Souza LM, Dale DC. Treatment of cyclic neutropenia with granulocyte colony stimulating factor. N Engl J Med 1989; 320: 1306.
6. Bonilla MA, Gillio AP, Ruggeiro M, et al. Effects of recombinant granulocyte-colony stimulating factor in patients with congenital agranulocytosis. N Engl J Med 1989; 320: 1574.
7. Bonilla MA, Dale D, Zeidler C, et al. Long-term safety of treatment with recombinant human granulocyte colony-stimulating factor (r-metHuG-CSF) in patients with severe congenital neutropenias. Br J Haematol 1994; 88: 723.
8. Gabrilove J. The development of granulocyte colony-stimulating factor in its various clinical applications. Blood 1992; 80: 1382.
9. Schmitz S, Franke H, Brusis J, Wichmann HE. Quantification of the cell kinetic effects of G-CSF using a model of human granulopoiesis. Exp Haematol 1993; 21: 755.
10. Lord BI, Bronchud MH, Owens S, et al. The kinetics of human granulopoiesis following treatment with granulocyte colony-stimulating factor in vivo. Proc Natl Acad Sci USA 1989; 86: 9499.
11. Coutinho LH, Will A, Radford J, Schiro R, Testa NG, Dexter TM. Effects of recombinant human granulocyte colony-stimulating factor (CSF), human granulocyte-macrophage-CSF, and gibbon interleukin-3 on hematopoiesis in human long-term bone marrow culture. Blood 1990; 75: 2118.
12. Bungart B, Loeffler M, Goris H, Dontje B, Diehl V, Nijhof W. Differential effects of recombinant human colony stimulating factor (rhG-CSF) on stem cells in marrow, spleen and peripheral blood in mice. Br J Haematol 1990; 76: 174.
13. Lieschke GJ, Burgess AW. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. N Engl J Med 1992; 327: 28.
14. Gabrilove JL, Jakubowski A, Fain K, et al. Phase I study of granulocyte colony-stimulating factor in patients with transitional cell carcinoma of the urothelium. J Clin Invest 1988; 82: 1454.
15. Morstyn G, Campbell L, Souza LM, et al. Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet 1988; 1: 667.
16. Lindemann A, Herrmann F, Oster W, et al. Hematologic effects of recombinant human granulocyte colony-stimulating factor in patients with malignancy. Blood 1989; 74: 2644.
17. Morstyn G, Lieschke GJ, Cebon J, et al. Early clinical trials with colony-stimulating factors. Cancer Invest 1989; 7: 443.
18. Morstyn G, Lieschke GJ, Sheridan W, Layton J, Cebon J. Pharmacology of the colony stimulating factors. Trends Pharmacol Sci 1989; 10: 154.
19. Bronchud MH, Potter MR, Morgenstern G, et al. In vitro and in vivo analysis of the effects of recombinant human granulocyte colony-stimulating factor in patients. Br J Cancer 1988; 58: 64.
20. Bronchud MH, Scarffe JH, Thatcher N, et al. Phase I/II study of recombinant human granulocyte colony stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer. Br J Cancer 1987; 56: 809.
21. Peddi VR, Hariharan S, Schroeder TJ, First MR. Role of granulocyte colony stimulating factor (G-CSF) in reversing neutropenia in renal allograft recipients. Clin Transplant 1996; 10: 20.
22. Minguez C, Mazuecos A, Ceballos M, Tejuca F, Rivero M. Worsening of renal function in a renal transplant patient with granulocyte colony-stimulating factor. Nephrol Dial Transplant 1995; 10: 2166.
23. Tajima A, Aso Y, Kawabe K, et al. Colony-stimulating factor for treatment of leukopenia after kidney allografting. Transplant Proc 1991; 23: 1369.
24. Calvar C, Martin JM, Gonzales-Molina M, et al. Granulocyte i colony-stimulating factor and leukopenia due to cytomegalovirus in a renal transplant patient. Nefrologia 1994; 14: 355.
25. Cruzado-Garrit JM, Gil-Vernet S, Moreso F, et al. Granulocyte-colony-stimulating factor as a treatment of leukopenia in a renal transplant recipient. Nefrologia 1993; 13: 588.
26. Birkeland SA, Elbirk A, Rohr N, Jorgensen KA. Severe neutropenia and its reversal with granulocyte colony stimulating factor. Transplant Proc 1994; 26: 3098.
27. Foster PF, Mital D, Sankary HN, et al. The use of granulocyte colony-stimulating factor after liver transplantation. Transplantation 1995; 59: 1557.
28. Donadieu J, Bader-Meunier B, Bertrand Y, et al. Recombinant human G-CSF (Lenograstim) for infectious complications in glycogen storage disease type Ib: report of 7 cases. Nouv Rev Fr Hematol 1994; 35: 529.
29. Colquhoun SD, Shaked A, Jurim O, Colonna JO, Rosove MH, Busuttil RW. Reversal of neutropenia with granulocyte colony-stimulating factor without precipitating liver allograft rejection. Transplantation 1993; 56: 755.
30. Patel HDL, Anderson JR, Duncombe AS, Carrington D, Murday A. Granulocyte colony-stimulating factor: a new application for cytomegalovirus-induced neutropenia in cardiac allograft recipients. Transplantation 1994; 58: 863.
31. Gordon MS, O'Donnell JA, Mohler ER, Copper MA. The use of granulocyte colony-stimulating factor in the treatment of fever and neutropenia in heart transplant patient. J Heart Lung Transplant 1993; 12: 706.
32. Pojda Z, Molineux G, Dexter TM. Hematopoietic effects of short-term in vivo treatment of mice with various doses of rhG-CSF. Exp Hematol 1990; 18: 27.
33. Molineux G, Pojda Z, Dexter TM. A comparison of hematopoiesis in normal and splenectomized mice treated with granulocyte colony stimulating factors. Blood 1990; 75: 563.
34. Lu L, Briddell RA, Graham CD, Brandt JE, Bruno E, Hoffman R. Effect of recombinant and purified hematopoietic growth factors on in vitro colony formation by enriched populations of human megakaryocyte progenitor cells. Br J Haematol 1988; 70: 149.
35. Bruno E, Briddell RA, Hoffman R. Effect of recombinant and purified hematopoietic growth factors on human megakaryocyte colony formation. Exp Hematol 1988; 16: 17.
36. Briddell RA, Brandt JE, Straneva JE, Srour EF, Hoffman R. Characterization of the human burst-forming unit-megakaryocyte. Blood 1989; 74: 145.
37. Perugini O, Montanari G, Nalli G. Trilineage response to granulocyte colony-stimulating factor administration in a patient with myelodysplastic syndrome. Haematologica 1995; 80: 234.
38. Park K, Im T, Sasaki A, et al. Positive effect of granulocyte-colony stimulating factor on erythropoiesis in humans. Osaka City Med J 1991; 37: 123.
39. Miles SA, Mitsuyasu RT, Lee K, et al. Recombinant human granulocyte colony-stimulating factor increases circulating burst forming unit-erythron and red cell production in patients with severe human immunodeficiency virus infection. Blood 1990; 75: 2137.
40. Page B, Morin M, Mamzer M, Thervet E, Legendre C. Use of granulocyte-macrophage colony-stimulating factor in leukopenic renal transplant recipients. Transplant Proc 1994; 26: 283.